Chronic fatigue syndrome: a review.
暂无分享,去创建一个
[1] M. Fujieda,et al. Defective killer cell activity in patients with chronic active Epstein-Barr virus infection. , 1988, Acta medica Okayama.
[2] P. White,et al. Strength and physiological response to exercise in patients with chronic fatigue syndrome , 2000, Journal of neurology, neurosurgery, and psychiatry.
[3] Joseph A Maldjian,et al. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome , 1999, Journal of the Neurological Sciences.
[4] M. Demitrack. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. , 1997, Journal of psychiatric research.
[5] Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. , 2001, The Journal of clinical endocrinology and metabolism.
[6] P Wallace,et al. Population based study of fatigue and psychological distress , 1994, BMJ.
[7] J. DeLuca,et al. Neuroimaging in chronic fatigue syndrome. , 1998, The American journal of medicine.
[8] Eisenberg,et al. Use of alternative treatments by chronic fatigue syndrome discordant twins. , 2000, Integrative medicine : integrating conventional and alternative medicine.
[9] L. Krupp,et al. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. , 1993, The Journal of neuropsychiatry and clinical neurosciences.
[10] E. Cassem. Depression and anxiety secondary to medical illness. , 1990, The Psychiatric clinics of North America.
[11] D. Buchwald,et al. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. , 1997, Arthritis and rheumatism.
[12] K. E. Lucas,et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. , 2001, JAMA.
[13] P. Sullivan,et al. Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.
[14] P. Manu,et al. Alpha-Delta Sleep in Patients With a Chief Complaint of Chronic Fatigue , 1994, Southern medical journal.
[15] V. Hesselbrock,et al. Depression among patients with a chief complaint of chronic fatigue. , 1989, Journal of affective disorders.
[16] A. Komaroff,et al. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. , 1990, Arthritis and rheumatism.
[17] S. Wessely,et al. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. , 1996, The American journal of psychiatry.
[18] S. Wessely,et al. Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[19] Susan K. Johnson,et al. Assessing Somatization Disorder in the Chronic Fatigue Syndrome , 1996, Psychosomatic medicine.
[20] J. Levy,et al. Immunologic abnormalities associated with chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] T. Dinan,et al. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects , 2000, Psychiatry Research.
[22] I. Salit. Precipitating factors for the chronic fatigue syndrome. , 1997, Journal of psychiatric research.
[23] P. White. The role of physical inactivity in the chronic fatigue syndrome. , 2000, Journal of psychosomatic research.
[24] P. White. The relationship between infection and fatigue. , 1997, Journal of psychosomatic research.
[25] A. Mann,et al. Chronic fatigue in primary care attenders , 1993, Psychological Medicine.
[26] J. Tilles,et al. alpha-Interferon treatment of patients with chronic fatigue syndrome. , 1996, Immunological investigations.
[27] D. Buchwald,et al. Chronic fatigue syndrome: an update. , 1998, Annual review of medicine.
[28] R. Booth,et al. Psychological influences on the perception of immune function , 1999, Psychological Medicine.
[29] H. Mayberg,et al. Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT. , 2001, Radiology.
[30] W. Mendelson,et al. Sleep disturbance in chronic fatigue syndrome. , 1993, Journal of psychosomatic research.
[31] I. Hickie,et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. , 1990, The American journal of medicine.
[32] D. Woodrow,et al. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome , 1998, Journal of neurology, neurosurgery, and psychiatry.
[33] D. Buchwald,et al. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. , 1996, The Journal of clinical investigation.
[34] D. Horrobin,et al. Effect of high doses of essential fatty acids on the postviral fatigue syndrome , 1990, Acta neurologica Scandinavica.
[35] H. Moldofsky,et al. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. , 1992, The Journal of rheumatology.
[36] R. Kessler,et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.
[37] G. Mcclearn,et al. Genetics and behavioral medicine: risk factors for cardiovascular disease. , 1997, Behavioral medicine.
[38] A. MacLeod,et al. Causal attributions about common somatic sensations among frequent general practice attenders , 1996, Psychological Medicine.
[39] C. Gottfries,et al. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome , 1998, European journal of pain.
[40] T. Marrie,et al. Cardiac function at rest and with exercise in the chronic fatigue syndrome. , 1989, Chest.
[41] P. White,et al. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome , 1997, International clinical psychopharmacology.
[42] S. Sisto,et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. , 1996, The American journal of medicine.
[43] A. Komaroff,et al. An examination of the working case definition of chronic fatigue syndrome. , 1996, The American journal of medicine.
[44] P. Garfinkel,et al. Chronic fatigue syndrome and depression: cause, effect, or covariate. , 1991, Reviews of infectious diseases.
[45] A. Hackmann,et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial , 1996, BMJ.
[46] P. Levine,et al. A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] G. Bleijenberg,et al. Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity , 2001, Psychological Medicine.
[48] I. Hickie,et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. , 1993, The American journal of medicine.
[49] W. Blackwelder,et al. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. , 2000, The Journal of rheumatology.
[50] John R. Evans,et al. Effects of Vitamin and Mineral Supplementation on Symptoms Associated with Chronic Fatigue Syndrome with Coxsackie B Antibodies , 1994 .
[51] D. Greenberg,et al. Neurasthenia in the 1980s: chronic mononucleosis, chronic fatigue syndrome, and anxiety and depressive disorders. , 1990, Psychosomatics.
[52] Juliea Morris,et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome† , 1998, British Journal of Psychiatry.
[53] R. Abs,et al. Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[54] S. Wessely,et al. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. , 1997, The American journal of psychiatry.
[55] R. Kikinis,et al. A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection , 1992, Annals of Internal Medicine.
[56] I. Hickie,et al. Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study , 1999, Psychological Medicine.
[57] D. Cioffi. BEYOND ATTENTIONAL STRATEGIES : A COGNITIVE-PERCEPTUAL MODEL OF SOMATIC INTERPRETATION , 1991 .
[58] M. Antoni,et al. Psychosocial correlates of illness burden in chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] W. Maixner,et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain , 1998, Pain.
[60] R. Perrin,et al. An evaluation of the effectiveness of osteopathic treatment on symptoms associated with myalgic encephalomyelitis. A preliminary report. , 1998, Journal of medical engineering & technology.
[61] S. Straus,et al. Psychiatric diagnoses in patients who have chronic fatigue syndrome. , 1989, The Journal of clinical psychiatry.
[62] B. Natelson,et al. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome , 1993, Journal of the Neurological Sciences.
[63] J. DeLuca,et al. Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. , 1996, Journal of affective disorders.
[64] M. Campbell,et al. Red blood cell magnesium and chronic fatigue syndrome , 1991, The Lancet.
[65] G. Bleijenberg,et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. , 1998, Journal of psychosomatic research.
[66] P. Levine,et al. Lessons from a pilot study of transfer factor in chronic fatigue syndrome , 1996, Biotherapy.
[67] O. Bon,et al. Sleep anomalies in the chronic fatigue syndrome. A comorbidity study. , 1997, Neuropsychobiology.
[68] S. Wessely,et al. Functional somatic syndromes: one or many? , 1999, The Lancet.
[69] R. Bentall,et al. A comparative psychiatric assessment of patients with chronic fatigue syndrome and muscle disease , 1991, Psychological Medicine.
[70] I. Hickie,et al. Unique genetic and environmental determinants of prolonged fatigue: a twin study , 1999, Psychological Medicine.
[71] D. Buchwald,et al. Coping strategies in twins with chronic fatigue and chronic fatigue syndrome. , 2000, Journal of psychosomatic research.
[72] A. David,et al. Neuroimaging in chronic fatigue syndrome. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[73] D. Bates,et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. , 1994, AJR. American journal of roentgenology.
[74] D. Bates,et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. , 1993, Archives of internal medicine.
[75] T. Findley,et al. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome , 1996, Psychopharmacology.
[76] P. Manu,et al. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. , 1993, Ciba Foundation symposium.
[77] Ian Hickie,et al. Prevalence of chronic fatigue syndrome in an Australian population , 1990, The Medical journal of Australia.
[78] Anne E. Figert,et al. From Paralysis to Fatigue: A History of Psychosomatic Illness in the Modern Era. , 1993 .
[79] A. Komaroff,et al. NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. , 1992, Annals of internal medicine.
[80] V. Seagroatt,et al. Follow up of patients presenting with fatigue to an infectious diseases clinic. , 1992, BMJ.
[81] R. Bentall,et al. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome , 2001, BMJ : British Medical Journal.
[82] F. Fouad-Tarazi,et al. The connection between chronic fatigue syndrome and neurally mediated hypotension. , 1998, Cleveland Clinic journal of medicine.
[83] P. Sullivan,et al. A Twin Study of Chronic Fatigue , 2001, Psychosomatic medicine.
[84] F A Jolesz,et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. , 1994, AJR. American journal of roentgenology.
[85] T. Field,et al. Massage Therapy Effects on Depression and Somatic Symptoms in Chronic Fatigue Syndrome , 1997 .
[86] M. Burnam,et al. Somatization in the community. , 1987, Archives of general psychiatry.
[87] W. Strober,et al. Lymphocyte phenotype and function in the chronic fatigue syndrome , 2004, Journal of Clinical Immunology.
[88] F. Zitman,et al. A randomized, placebo-controlled, double-blind study of fluoxetine in Chronic Fatigue Syndrome , 1996 .
[89] J. DeLuca,et al. Neuropsychology of chronic fatigue syndrome: a critical review. , 1997, Journal of clinical and experimental neuropsychology.
[90] B. Natelson,et al. Impaired oxygen delivery to muscle in chronic fatigue syndrome. , 1999, Clinical science.
[91] W. Weir,et al. Interferon-alpha therapy for patients with chronic fatigue syndrome. , 1993, The Journal of infectious diseases.
[92] M. Hotopf,et al. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. , 1997, QJM : monthly journal of the Association of Physicians.
[93] W. Weir,et al. Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. , 1997, Journal of psychosomatic research.
[94] M. Caligiuri,et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. , 1987, Journal of immunology.
[95] J. Bellanti,et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[96] I. Hickie,et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. , 1997, The American journal of medicine.
[97] D. Smallwood,et al. An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome. , 1997, Journal of psychiatric research.
[98] H. Calkins,et al. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. , 1995, JAMA.
[99] M. Mckendrick,et al. The role of essential fatty acids in chronic fatigue syndrome: A case‐controlled study of red‐cell membrane essential fatty acids (EFA) and a placebo‐controlled treatment study with high dose of EFA , 1999, Acta neurologica Scandinavica.
[100] K. Kendler,et al. A psychiatric dialogue on the mind-body problem. , 2001, The American journal of psychiatry.
[101] D. Mccluskey,et al. Aerobic work capacity in patients with chronic fatigue syndrome. , 1990, BMJ.
[102] P. Manu,et al. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. , 1990, The American journal of the medical sciences.
[103] I. Hickie,et al. The treatment of chronic fatigue syndrome: science and speculation. , 1994, The American journal of medicine.
[104] E. Paykel,et al. A family history study of chronic fatigue syndrome , 2001, Psychiatric genetics.
[105] A. Hackmann,et al. Chronic fatigue syndrome: a cognitive approach. , 1995, Behaviour research and therapy.
[106] S. Wessely,et al. Causal attributions for somatic sensations in patients with chronic fatigue syndrome and their partners , 2001, Psychological Medicine.
[107] D. Buchwald,et al. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. , 1996, Medical care.
[108] D. Stewart,et al. Emotional Disorders Misdiagnosed as Physical Illness: Environmental Hypersensitivity, Candidiasis Hypersensitivity, and Chronic Fatigue Syndrome , 1990 .
[109] N. Lurie,et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. , 1996, The Journal of allergy and clinical immunology.
[110] J. Levy,et al. Chronic fatigue syndrome: clinical condition associated with immune activation , 1991, The Lancet.
[111] P. Keck,et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. , 1992, The American journal of medicine.
[112] D. Buchwald,et al. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. , 1994, Archives of internal medicine.
[113] I. Hickie,et al. The Psychiatric Status of Patients with the Chronic Fatigue Syndrome , 1990, British Journal of Psychiatry.
[114] P. Behan,et al. Changes in natural killer cell phenotype in patients with post‐viral fatigue syndrome , 1991, Clinical and experimental immunology.
[115] L. Jason,et al. Chronic Fatigue Syndrome, Fibromyalgia, and Multiple Chemical Sensitivities in a Community-Based Sample of Persons With Chronic Fatigue Syndrome-Like Symptoms , 2000, Psychosomatic medicine.
[116] M. Power,et al. Chronic fatigue in the community: ‘A question of attribution’ , 1996, Psychological Medicine.
[117] R. Edwards,et al. The metabolic consequences of reduced habitual activities in patients with muscle pain and disease. , 1988, Ergonomics.
[118] C. Bisbal,et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. , 2000, The American journal of medicine.
[119] D. Wood,et al. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. , 1988, JAMA.
[120] S. Wessely,et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. , 1997, American journal of public health.
[121] R. Murray,et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome , 1995, Biological Psychiatry.
[122] A. Thurm,et al. Chronic fatigue syndrome in children and adolescents: a review. , 1998, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[123] M. Chen. The epidemiology of self-perceived fatigue among adults. , 1986, Preventive medicine.
[124] L. Rucker,et al. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. , 1989, Archives of internal medicine.
[125] P. Whiting,et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. , 2001, JAMA.
[126] A. Mann,et al. Tired, weak, or in need of rest: fatigue among general practice attenders. , 1990, BMJ.
[127] P. Tugwell,et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.
[128] M. Hotopf,et al. Viruses, neurosis and fatigue. , 1994, Journal of psychosomatic research.
[129] Renée R Taylor,et al. Chronic Fatigue Syndrome , 2000, Evaluation & the health professions.
[130] M. Speechley,et al. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. , 2000, Scandinavian journal of rheumatology.
[131] M. Fletcher,et al. Immunologic abnormalities in chronic fatigue syndrome , 1990, Journal of clinical microbiology.
[132] M. Sharpe,et al. A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.
[133] R. Cluydts,et al. Generalized anxiety disorder in chronic fatigue syndrome , 1997, Acta psychiatrica Scandinavica.
[134] I. Hickie,et al. Longitudinal study of outcome of chronic fatigue syndrome , 1994, BMJ.
[135] T. Dinan,et al. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.
[136] M. Demitrack,et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.
[137] W. Katon,et al. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. , 1996, The American journal of medicine.
[138] P. Manu,et al. The mental health of patients with a chief complaint of chronic fatigue. A prospective evaluation and follow-up. , 1988, Archives of internal medicine.
[139] Susan K. Johnson,et al. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[140] D. Buchwald,et al. Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. , 2000, Archives of internal medicine.
[141] H. Calkins,et al. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? , 1995, The Lancet.
[142] D. Buchwald,et al. Significant Other Responses Are Associated With Fatigue and Functional Status Among Patients With Chronic Fatigue Syndrome , 2000, Psychosomatic medicine.
[143] H. Pope,et al. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? , 1990, The American journal of psychiatry.
[144] L. Krupp,et al. A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[145] S. Swan,et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. , 1998, Archives of internal medicine.
[146] Susan K. Johnson,et al. Chronic fatigue syndrome: Reviewing the research findings , 1999, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[147] R. Goshorn. Chronic Fatigue Syndrome: A Review for Clinicians , 1998, Seminars in neurology.
[148] R. Schweitzer,et al. Illness behaviour of patients with chronic fatigue syndrome. , 1994, Journal of psychosomatic research.
[149] P. McGuffin,et al. Is disabling fatigue in childhood influenced by genes? , 1999, Psychological Medicine.
[150] P. Keck,et al. Antidepressant treatment of fibromyalgia. A meta-analysis and review. , 2000, Psychosomatics.
[151] M. Sharpe,et al. Do patients with "pure" chronic fatigue syndrome (neurasthenia) have abnormal sleep? , 1997, Psychosomatic medicine.
[152] G. Bleijenberg,et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. , 1996, Archives of neurology.
[153] P. Manu,et al. Depression and somatization in the chronic fatigue syndrome. , 1991, The American journal of medicine.
[154] K Y Fulcher,et al. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome , 1997, BMJ.
[155] S. Kisely. Treatments for Chronic Fatigue Syndrome and the Internet: A Systematic Survey of what Your Patients are Reading , 2002, The Australian and New Zealand journal of psychiatry.
[156] M. Demitrack,et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. , 1998, JAMA.
[157] K. Stefánsson,et al. Trial of a Selective Acetylcholinesterase Inhibitor, Galanthamine Hydrobromide, in the Treatment of Chronic Fatigue Syndrome , 1996 .
[158] S. Wessely,et al. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. , 1997, Clinical immunology and immunopathology.
[159] W. Saxinger,et al. Natural Killer Cell Activity in the Chronic Fatigue-Immune Dysfunction Syndrome , 1989 .
[160] R. Cluydts,et al. Neuropsychological functioning in chronic fatigue syndrome: a review , 2001, Acta psychiatrica Scandinavica.
[161] K. Petrie,et al. Cognitive distortions of somatic experiences: revision and validation of a measure. , 1997, Journal of psychosomatic research.
[162] B. Natelson,et al. Single-Blind, Placebo Phase-in Trial of Two Escalating Doses of Selegiline in the Chronic Fatigue Syndrome , 1998, Neuropsychobiology.
[163] James F. Jones,et al. Pain Perception in Chronic Fatigue Syndrome , 1998 .
[164] S. Wessely,et al. Chronic fatigue syndrome: a follow up study. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[165] A. Fry,et al. Fatigue in the chronic fatigue syndrome: a cognitive phenomenon? , 1996, Journal of psychosomatic research.
[166] S. Wessely,et al. Illness beliefs and treatment outcome in chronic fatigue syndrome. , 1998, Journal of psychosomatic research.
[167] R. Dolan,et al. Attributions and self-esteem in depression and chronic fatigue syndromes. , 1990, Journal of psychosomatic research.
[168] Simon Wessely,et al. Chronic Fatigue Syndrome , 1996, BMJ : British Medical Journal.
[169] S. Wessely,et al. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. , 2001, The American journal of psychiatry.
[170] W. Reeves,et al. The epidemiology of chronic fatigue in San Francisco. , 1998, The American journal of medicine.
[171] W. M. Goldberg,et al. An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls. , 1998, The American journal of medicine.
[172] D. Oken. Multiaxial Diagnosis and the Psychosomatic Model of Disease , 2000, Psychosomatic medicine.
[173] N. Lurie,et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. , 1990, The American journal of medicine.
[174] D. T. Graham. Health, Disease, and the Mind‐Body Problem: Linguistic Parallelism , 1967, Psychosomatic medicine.
[175] M. Heijmans. Coping and adaptive outcome in chronic fatigue syndrome: importance of illness cognitions. , 1998, Journal of psychosomatic research.
[176] D. Buchwald,et al. Sleep disorders in patients with chronic fatigue. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[177] K. Petrie,et al. Functioning in chronic fatigue syndrome: Do illness perceptions play a regulatory role? , 1996 .
[178] A. Komaroff,et al. Does the chronic fatigue syndrome involve the autonomic nervous system? , 1997, The American journal of medicine.
[179] K. Rospenda,et al. Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies? , 1994, American journal of public health.
[180] S. Lautenbacher,et al. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia , 1994, Pain.
[181] M Freedman,et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. , 1992, Nuclear medicine communications.
[182] G. Bleijenberg,et al. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. , 2000, Journal of psychosomatic research.
[183] P. Morse,et al. Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue. , 1996, Psychotherapy and psychosomatics.
[184] B. Kendall,et al. Cognitive Functioning and Magnetic Resonance Imaging in Chronic Fatigue , 1995, British Journal of Psychiatry.
[185] D. Farrar,et al. Chronic fatigue syndrome. 1: Etiology and pathogenesis. , 1995, Behavioral medicine.
[186] A. Mann,et al. Psychosocial risk factors for chronic fatigue and chronic fatigue syndrome following presumed viral illness: a case–control study , 1996, Psychological Medicine.
[187] R. Kydd,et al. Neuropsychological deficits in chronic fatigue syndrome: artifact or reality? , 1996, Journal of neurology, neurosurgery, and psychiatry.
[188] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[189] P. Garfinkel,et al. The Neuropsychological Dimensions of Postinfectious Neuromyasthenia (Chronic Fatigue Syndrome): A Preliminary Report , 1990, International journal of psychiatry in medicine.
[190] I. Hickie,et al. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. , 2000, The Journal of clinical psychiatry.
[191] P. Cowen,et al. Abnormalities of sleep in patients with the chronic fatigue syndrome. , 1993, BMJ.
[192] P. Dendale,et al. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. , 1997, Journal of psychosomatic research.
[193] W. Reeves,et al. Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[194] D. Buchwald,et al. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. , 2000, Archives of internal medicine.
[195] S. Wessely,et al. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia , 2001, Psychological Medicine.
[196] James M Barker,et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. , 1996, The American journal of medicine.
[197] A. Komaroff,et al. Chronic Fatigue and the Chronic Fatigue Syndrome: Prevalence in a Pacific Northwest Health Care System , 1995, Annals of Internal Medicine.
[198] N. McGregor,et al. Exercise capacity in chronic fatigue syndrome. , 2000, Archives of internal medicine.
[199] P. Manu,et al. Somatization disorder in patients with chronic fatigue. , 1989, Psychosomatics.